On, January 24, 2015, the IGI convened a small and elite group of prominent researchers and thought-leaders in the fields of genome editing, bioethics and law to discuss current issues and revelations in the field of genome engineering and the important ramifications that the new CRISPR–Cas9 technology has already begun to have on research and industry. A summary of the group’s recommendations was published in the journal Science and led to the NAS-hosted International Summit on Human Gene Editing in Washington, DC, on December 1–3, 2015.
A prudent path forward for genomic engineering and germline gene modification
Science | March 19, 2015
Authors: David Baltimore, Paul Berg, Michael Botchan, Dana Carroll, R. Alta Charo, George Church, Jacob E. Corn, George Q. Daley, Jennifer A. Doudna, Marsha Fenner, Henry T. Greely, Martin Jinek, G. Steven Martin, Edward Penhoet, Jennifer Puck, Samuel H. Sternberg, Jonathan S. Weissman, Keith R. Yamamoto
Bioethics Workshop, Napa, CA, January 24, 2015
Left to right: Michael Botchan, Sam Sternberg, Paul Berg, Jonathan Weissman, David Baltimore, Jacob Corn, Keith Yamamoto, Ed Penhoet, Dana Carroll, George Daley, Alta Charo, Hank Greely, Jennifer Doudna, G. Steve Martin, Marsha Fenner and Jennifer Puck.